2026年女性健康投资前景分析报告_填补缺口与释放未开发市场潜力_47页_6mb

Women’s Health Investment Outlook Summary

Core Content

This report highlights the significant underinvestment in women's health, despite women comprising nearly half of the global population and being central to healthcare decision-making. It outlines the opportunities for investment, the current state of funding, and the barriers that persist, emphasizing the need for coordinated, evidence-based action to close the gap.

Main Points

• Underinvestment: Women's health receives only 6% of private healthcare investment, with companies focused exclusively on women's health capturing less than 1%.

• Market Potential: The market for women's health is large and underdeveloped, with potential for $100 billion+ in the U.S. alone by 2030 if key conditions are addressed.

• Key Barriers:

  • Limited foundational science: Historically, women were excluded from clinical trials, leading to a lack of sex-disaggregated data.
  • Reimbursement gaps: Coverage for women's health is inconsistent and often limited.
  • Fragmented financing: No clear "home" in mainstream capital markets.
  • Measurement gaps: Inconsistent data on prevalence, outcomes, and ROI makes market sizing difficult.
  • Regulatory friction: Standards based on male physiology and exclusion of pregnant/lactating women from trials increase risk and extend timelines.
  • Early-stage concentration: 70-80% of women's health deals are early-stage, limiting scalability and attracting institutional investment.

• Investment Index: The Women's Health Investment Index tracks private-sector capital flows in women's health across therapeutic areas, industry segments, and investment stages. It provides transparency and highlights areas with high potential for investment and growth.

• Case Study: IVF:

  • Proof of scale: IVF has evolved from a niche, stigmatized field to a $13 billion global market, demonstrating the potential for women's health innovation.
  • Drivers of growth: Scientific advancements, increased demand due to cultural and demographic shifts, and policy and reimbursement support have been key.
  • Investor role: Investors have played a critical role in shaping the ecosystem, standardizing delivery models, and consolidating networks.

Key Investment Areas

The report identifies six high-potential areas for investment:

1. Women's Cancer Therapeutics
2. Virtual Women's Healthcare and Benefits Management
3. Remote Maternal Health Monitoring
4. Women-Focused Mental Health Platforms
5. Women-First Longevity and Wellness Concierge Services
6. Wearable Devices and Platforms for Women's Metabolic Health

These areas represent both current activity and forward-looking signals for investment.

Call to Action

To unlock the potential of women's health, the report calls for six key actions:

1. Build a demand-driven evidence base with sex-specific research and real-world outcomes.
2. Mobilize blended capital to bridge the translational "valley of death" and attract private investment.
3. Modernize regulatory and clinical endpoints to accelerate market entry.
4. Expand reimbursement to establish predictable revenue models.
5. Encourage participation from adjacent incumbents with capabilities to address women-specific needs.
6. Increase transparency on economic returns and clinical outcomes to enable informed investment decisions.

Conclusion

The women's health market is a high-growth, underdeveloped sector with significant untapped potential. Addressing the investment gap requires a multifaceted approach that includes better data, improved reimbursement, regulatory reform, and a shift in investment strategies to reflect the unique needs of women. The Women's Health Investment Index serves as a valuable tool to guide investors, policymakers, and innovators in directing capital towards areas with the greatest potential for impact and return.

Key Statistics

• 6% of private healthcare investment goes to women's health.
• 25% more of women's lives are spent in poor health or with a disability compared to men.
• $100 billion+ market opportunity in the U.S. for women's health conditions by 2030.
• 80% of funding events and 90% of capital flow into three areas: women's cancers, reproductive health, and maternal health.
• 70-80% of women's health deals are early-stage.
• IVF has grown into a $13 billion market, showing the potential for similar growth in other areas.